Expert insights. Personalized for you.
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas. MORE
The Drug Enforcement Administration (DEA) got a slap on the wrist from a federal watchdog agency over its management of a multi-million dollar marijuana eradication program. In a report released on Wednesday, the non-partisan Government Accountability Office (GAO) said the DEA had failed to adequately collect documentation from state and local law enforcement partners that received funds through the federal program. MORE
As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received. MORE
In January of 2021, Tucker wrote a letter to the DEA asking for access to psilocybin under the Right to Try (RTT) Act, which was designed for terminally ill patients who do not have time to wait for drug approval. At that point, the team decided to sue the DEA to change its decision. “I MORE
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 In 2011, for instance, the DEA seized over 8.7 MORE
Buzzfeed News first reported that the Department of Justice expanded the Drug Enforcement Administration’s (DEA) jurisdiction in response to these protests. Now, the DEA does not even need to suspect a drug crime has been committed to take action against protesters. MORE
Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. In 2016, the DEA finally shifted to different treatment around expanded research efforts into cannabis beyond Ole Miss. MORE
Research SCIENCE Congress DEA research Senate University of MississippiFor over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies. MORE
One could argue at the moment that some US Federal Agencies have employees on the books who could be accused via their behaviour of scamming … Read More. Breaking News MORE
Well that came out of the blue in the midst of all the other dire news racing through the sector. Cannabis Business Times reports Effective … Read More. Breaking News MORE
The post DEA Report: Marijuana Seizures at Southern Border Have Fallen Significantly Following Passage of Statewide Legalization Laws appeared first on NORML. LAW ENFORCEMENT DEA Mexico seizures southern border MORE
SUMMARY: The Drug Enforcement Administration (DEA) is amending its regulations to facilitate the cultivation of … Read More. The post Document – DEA: Controls To Enhance the Cultivation of Marihuana for Research in the United States first appeared on Cannabis Law Report. MORE
The hemp has hit the fan…… California’s Bureau of Cannabis Control had refused to give the DEA those documents, arguing in court filings that the … Read More. MORE
Today, we focus on some of the high-level requirements of the Drug Enforcement Agency (DEA) on clinics and their personnel. In other words, not just anyone can obtain a DEA registration and dispense ketamine. The post Ketamine Clinics and the DEA appeared first on Harris Bricken MORE
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. However, most of those applications have been before DEA for several years, and the agency still has yet to provide any explicit timeline regarding when, if ever it intends to act on them. MORE
The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020. Last week, nine members of Congress issued a letter to the DEA’s Acting Administrator, Timothy Shea, to express their concerns regarding the Rule. MORE
The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly. Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year. Health Politics cannabidiol cbd Epidiolex GW Pharma GW Pharmaceuticals MORE
” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.). “While most states recognize that cannabis has medical value, the DEA says otherwise, pointing to the absence of clinical research. MORE
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. According to the agency’s filing today in the Federal Register, the DEA “intends to promulgate regulations” to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. FDA GOVERNMENT SCIENCE DEA medical research University of Mississippi MORE
On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes. MORE
Drug Enforcement Administration (“DEA”) to reschedule marijuana. As we all know, the DEA has routinely refused to accept or denied each and every petition, minus one that yielded very specific changes for a synthetic cannabis drug. The DEA’s answering brief is due November 30, 2020. MORE
If you answered yes to these two questions, then the DEA might have the job for you. The DEA is seeking a contractor that has the ability to destroy illegal drugs without leaving detectable levels behind. The DEA Says That This isn’t a Job Announcement . MORE
According to a DEA memorandum , the agency requested to expand its policing powers beyond the enforcement of federal drug laws to include the enforcement of “any federal crime committed as a result of protests over the death of George Floyd.” MORE
A vague memory tells us that the DEA were looking for a contractor early 2019 ? The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor. Marijuana Moment has … Read More. MORE
Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research MORE
District Court to block the DEA from unlawfully criminalizing hemp production The lawsuit also highlights the DEA’s history of … Read More. The detailed complaint asks a U.S. MORE
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. However, the DEA does not keep its staff employed without drugs to seize, with marijuana being an easy target. It could be argued that the DEA is hesitant for the sake of public safety. Here, DEA can act with little expenditure of resources.”. MORE
The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. DEA Interim Final Rule: What Is “Synthetically Derived THC”? The DEA Does Not Want You To Worry About Its New Hemp Rule. The Hemp Industry Responds to the DEA Rule With a Lawsuit. MORE
The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. In 2016, the DEA publicly announced that it would, for the first time, begin accepting applications from private entities wishing to grow research-grade cannabis. MORE
The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. DEA Report Shows Federal Prohibition Efforts Continue Despite State-Level Reforms. MORE
The post DEA Asks Court To Overturn Cannabis Rescheduling Appeal first appeared on Cannabis Law Report. The U.S. MORE
In the context of “synthetic marijuana,” which the DEA describes as a “synthetic version of THC,” “synthetic THC” refers to a mixture of plant material sprayed with synthetic psychoactive chemicals. MORE
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 However, while the total number of DEA-seized plants fell in 2018, seizures of indoor cannabis plants nearly doubled – rising from 304,000 plants in 2017 to just under 600,000 in 2018. LAW ENFORCEMENT assets DEA eradication legalization seizures MORE
On December 3, 2020, MAPS (the Multidisciplinary Association for Psychedelic Studies) issued a press release regarding a lawsuit filed against the DEA and the Attorney General to “compel issuance of licenses to manufacture marijuana for clinical trials and potential FDA approval.” MORE
The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. MORE
The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. appeared first on Leafly. MORE
DEA Related Topics NORML
MARCH 3, 2021
The post DEA Report: Marijuana Seizures at Southern Border Have Fallen Significantly Following Passage of Statewide Legalization Laws appeared first on NORML. LAW ENFORCEMENT DEA Mexico seizures southern border
NORML
APRIL 14, 2020
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 In 2011, for instance, the DEA seized over 8.7
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
APRIL 8, 2020
As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received.
NORML
APRIL 13, 2021
The post NORML Comments on Biden’s Pick for DEA Administrator appeared first on NORML. Former NJ Attorney General to be Nominated to Lead Agency. LAW ENFORCEMENT Federal milgram nominee
NORML
MARCH 26, 2020
The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. In 2016, the DEA publicly announced that it would, for the first time, begin accepting applications from private entities wishing to grow research-grade cannabis.
Leafly
JUNE 8, 2020
The DEA's five-part test to determine 'currently accepted medical use' is flawed, say the plaintiffs. The post New lawsuit aims to force DEA to reschedule marijuana appeared first on Leafly.
NORML
AUGUST 26, 2019
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. According to the agency’s filing today in the Federal Register, the DEA “intends to promulgate regulations” to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. FDA GOVERNMENT SCIENCE DEA medical research University of Mississippi
Canna Law Blog
OCTOBER 17, 2020
The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids.
SpeedWeed
MAY 11, 2021
The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. DEA Report Shows Federal Prohibition Efforts Continue Despite State-Level Reforms.
HarrisBricken
MAY 5, 2021
The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. DEA Interim Final Rule: What Is “Synthetically Derived THC”? The DEA Does Not Want You To Worry About Its New Hemp Rule. The Hemp Industry Responds to the DEA Rule With a Lawsuit.
NORML
JUNE 3, 2020
According to a DEA memorandum , the agency requested to expand its policing powers beyond the enforcement of federal drug laws to include the enforcement of “any federal crime committed as a result of protests over the death of George Floyd.”
|
Leafly
MARCH 22, 2019
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.
Canna Law Blog
JUNE 17, 2020
Buzzfeed News first reported that the Department of Justice expanded the Drug Enforcement Administration’s (DEA) jurisdiction in response to these protests. Now, the DEA does not even need to suspect a drug crime has been committed to take action against protesters.
Americans for Safe Access
JUNE 2, 2020
On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.
Leafly
AUGUST 26, 2019
Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research
Cannabis Law Report
DECEMBER 3, 2020
The post DEA Asks Court To Overturn Cannabis Rescheduling Appeal first appeared on Cannabis Law Report. The U.S.
NORML
OCTOBER 21, 2019
Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. However, most of those applications have been before DEA for several years, and the agency still has yet to provide any explicit timeline regarding when, if ever it intends to act on them.
Cannabis Law Report
JULY 29, 2020
One could argue at the moment that some US Federal Agencies have employees on the books who could be accused via their behaviour of scamming … Read More. Breaking News
Canna Law Blog
JUNE 11, 2020
Today, we focus on some of the high-level requirements of the Drug Enforcement Agency (DEA) on clinics and their personnel. In other words, not just anyone can obtain a DEA registration and dispense ketamine. The post Ketamine Clinics and the DEA appeared first on Harris Bricken
Cannabis Law Report
OCTOBER 27, 2020
A vague memory tells us that the DEA were looking for a contractor early 2019 ? The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor. Marijuana Moment has … Read More.
SpeedWeed
MARCH 11, 2021
In January of 2021, Tucker wrote a letter to the DEA asking for access to psilocybin under the Right to Try (RTT) Act, which was designed for terminally ill patients who do not have time to wait for drug approval. At that point, the team decided to sue the DEA to change its decision. “I
NORML
AUGUST 2, 2019
” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.). “While most states recognize that cannabis has medical value, the DEA says otherwise, pointing to the absence of clinical research.
WeedAdvisor
JULY 4, 2019
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. However, the DEA does not keep its staff employed without drugs to seize, with marijuana being an easy target. It could be argued that the DEA is hesitant for the sake of public safety. Here, DEA can act with little expenditure of resources.”.
HarrisBricken
DECEMBER 18, 2020
On December 3, 2020, MAPS (the Multidisciplinary Association for Psychedelic Studies) issued a press release regarding a lawsuit filed against the DEA and the Attorney General to “compel issuance of licenses to manufacture marijuana for clinical trials and potential FDA approval.”
Leafly
AUGUST 19, 2019
The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. appeared first on Leafly.
MassRoots
NOVEMBER 19, 2018
The Drug Enforcement Administration (DEA) got a slap on the wrist from a federal watchdog agency over its management of a multi-million dollar marijuana eradication program. In a report released on Wednesday, the non-partisan Government Accountability Office (GAO) said the DEA had failed to adequately collect documentation from state and local law enforcement partners that received funds through the federal program.
Leafly
APRIL 6, 2020
The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly. Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year. Health Politics cannabidiol cbd Epidiolex GW Pharma GW Pharmaceuticals
Cannabis Law Report
APRIL 7, 2020
Well that came out of the blue in the midst of all the other dire news racing through the sector. Cannabis Business Times reports Effective … Read More. Breaking News
Canna Law Blog
AUGUST 24, 2020
In the context of “synthetic marijuana,” which the DEA describes as a “synthetic version of THC,” “synthetic THC” refers to a mixture of plant material sprayed with synthetic psychoactive chemicals.
Canna Law Blog
MAY 7, 2020
Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. In 2016, the DEA finally shifted to different treatment around expanded research efforts into cannabis beyond Ole Miss.
Cannabis Law Report
DECEMBER 18, 2020
SUMMARY: The Drug Enforcement Administration (DEA) is amending its regulations to facilitate the cultivation of … Read More. The post Document – DEA: Controls To Enhance the Cultivation of Marihuana for Research in the United States first appeared on Cannabis Law Report.
Canna Law Blog
OCTOBER 23, 2020
Drug Enforcement Administration (“DEA”) to reschedule marijuana. As we all know, the DEA has routinely refused to accept or denied each and every petition, minus one that yielded very specific changes for a synthetic cannabis drug. The DEA’s answering brief is due November 30, 2020.
Cannabis Law Report
OCTOBER 12, 2020
District Court to block the DEA from unlawfully criminalizing hemp production The lawsuit also highlights the DEA’s history of … Read More. The detailed complaint asks a U.S.
Veriheal
DECEMBER 30, 2020
If you answered yes to these two questions, then the DEA might have the job for you. The DEA is seeking a contractor that has the ability to destroy illegal drugs without leaving detectable levels behind. The DEA Says That This isn’t a Job Announcement .
Canna Law Blog
OCTOBER 29, 2020
The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020. Last week, nine members of Congress issued a letter to the DEA’s Acting Administrator, Timothy Shea, to express their concerns regarding the Rule.
Cannabis Law Report
SEPTEMBER 1, 2020
The hemp has hit the fan…… California’s Bureau of Cannabis Control had refused to give the DEA those documents, arguing in court filings that the … Read More.
NORML
DECEMBER 16, 2020
Research SCIENCE Congress DEA research Senate University of MississippiFor over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies.
88 
Let's personalize your content